Brawn Biotech Limited share price
BSE: BRAWN
Key numbers
- Market cap
- ₹ 6.5 Cr
- Current price
- ₹ 21.49
- 52-week high / low
- ₹ 24 / 18
- Stock P/E
- 7.4
- Book value
- ₹ 14.5
- Dividend yield
- 0.00%
- ROCE
- 0.0%
- ROE
- 24.4%
- Debt to equity
- 0.00
- Sales growth (3 yrs)
- -11.1%
- Profit growth (3 yrs)
- -
- 1-year return
- -4.7%
About Brawn Biotech Limited
Brawn Biotech Limited trades in pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 6 | 5 | 4 | 2 | 6 |
| Operating profit | 0 | 0 | -0 | -1 | 0 |
| Net profit | 0 | 0 | 0 | 1 | 0 |
| EPS (₹) | 0.89 | 0.25 | 0.17 | 1.95 | 0.52 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.